Illumina 2022 J.P. Morgan Healthcare Conference

Illumina presented at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, with President & CEO Francis deSouza discussing the company's genomic sequencing platforms, products, and services. The presentation covered forward-looking statements regarding product development, commercialization efforts including the GRAIL cancer screening test, and recent acquisitions.